{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:03:11Z","timestamp":1777485791598,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National institutes for health helping to end addiction long term initiative","award":["U24HD095254"],"award-info":[{"award-number":["U24HD095254"]}]},{"name":"National institutes for health helping to end addiction long term initiative","award":["U2COD023375"],"award-info":[{"award-number":["U2COD023375"]}]},{"name":"National institutes for health helping to end addiction long term initiative","award":["U24OD023957"],"award-info":[{"award-number":["U24OD023957"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The incidence of maternal opioid use in the USA has increased substantially since 2000. As a consequence of opioid use during pregnancy, the incidence of neonatal opioid withdrawal syndrome (NOWS) has increased fivefold between 2002 and 2012. Pharmacological therapy is indicated when signs of NOWS cannot be controlled, and the objective of pharmacological therapy is to control NOWS signs. Once pharmacologic therapy has started, there is great variability in strategies to wean infants. An important rationale for studying weaning of pharmacological treatment for NOWS is that weaning represents the longest time interval of drug treatment. Stopping medications too early may not completely treat NOWS symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This will be a pragmatic, randomized, blinded trial of opioid weaning to determine whether more rapid weaning, compared to slow wean, will reduce the number of days of opioid treatment in infants receiving morphine or methadone as the primary treatment for NOWS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The proposed study is a pragmatic trial to determine whether a rapid-weaning intervention reduces the number of days of opioid treatment, compared to a slow-weaning intervention, and we powered the proposed study to detect a 2-day difference in the length of treatment. Hospitals will be able to use either morphine or methadone with the knowledge that we may find a positive treatment effect for both, one, or neither drugs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>NCT04214834. Registered January 2, 2020.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-023-07378-x","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T13:02:17Z","timestamp":1689944537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS)"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0062-0731","authenticated-orcid":false,"given":"Adam","family":"Czynski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbot","family":"Laptook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhik","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Annett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannette","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Snowden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Pedroza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Lester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Eggleston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drew","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"issue":"18","key":"7378_CR1","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.2012.3951","volume":"307","author":"SW Patrick","year":"2012","unstructured":"Patrick SW, et al. Neonatal abstinence syndrome and associated health care expenditures. United States, 2000-2009. JAMA. 2012;307(18):1934\u201340.","journal-title":"JAMA"},{"issue":"25","key":"7378_CR2","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1056\/NEJMra1600879","volume":"375","author":"K McQueen","year":"2016","unstructured":"McQueen K, Murphy-Oikonen J. Neonatal Abstinence syndrome. N Eng J Med. 2016;375(25):2468\u201379.","journal-title":"N Eng J Med"},{"issue":"Suppl 1","key":"7378_CR3","first-page":"35","volume":"12","author":"NA Jumah","year":"2016","unstructured":"Jumah NA. Rural, pregnant, and opioid dependent: a systematic review. Substance Review. 2016;12(Suppl 1):35\u201341.","journal-title":"Substance Review"},{"key":"7378_CR4","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/jp.2015.36","volume":"35","author":"SW Patrick","year":"2015","unstructured":"Patrick SW, et al. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States, 2009 to 2012. J Perinatol. 2015;35:650\u20135.","journal-title":"J Perinatol"},{"issue":"22","key":"7378_CR5","doi-asserted-by":"publisher","first-page":"21182126","DOI":"10.1056\/NEJMsa1500439","volume":"372","author":"VN Tolia","year":"2015","unstructured":"Tolia VN, et al. Increasing incidence of the neonatal abstinence syndrome in US Neonatal ICUs. N Eng J Med. 2015;372(22):21182126.","journal-title":"N Eng J Med"},{"issue":"4","key":"7378_CR6","doi-asserted-by":"publisher","first-page":"e20173520","DOI":"10.1542\/peds.2017-3520","volume":"141","author":"TNA Winkelman","year":"2018","unstructured":"Winkelman TNA, Villapiano N, Kozhimannil KB, Davis MM, Patrick SW. Incidence and costs of neonatal abstinence syndrome among infants with Medicaid: 2004\u20132014. Pediatrics. 2018;141(4):e20173520.","journal-title":"Pediatrics."},{"key":"7378_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/AOG.0000000000002054","volume":"130","author":"UM Reddy","year":"2017","unstructured":"Reddy UM, et al. Opioid use in pregnancy, neonatal abstinence syndrome and childhood outcomes. Obstet Gynecol. 2017;130:10\u201328.","journal-title":"Obstet Gynecol"},{"key":"7378_CR8","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.jpeds.2015.09.047","volume":"167","author":"SW Patrick","year":"2015","unstructured":"Patrick SW. The triple aim for neonatal abstinence syndrome. J Pediatr. 2015;167:1189\u201391.","journal-title":"J Pediatr"},{"issue":"13","key":"7378_CR9","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1001\/jama.2018.2640","volume":"319","author":"EM Wachman","year":"2018","unstructured":"Wachman EM, et al. Neonatal abstinence syndrome: advances in diagnosis and treatment. JAMA. 2018;319(13):1362\u201374.","journal-title":"JAMA"},{"issue":"6","key":"7378_CR10","doi-asserted-by":"publisher","first-page":"e20152929","DOI":"10.1542\/peds.2015-2929","volume":"137","author":"AV Holmes","year":"2016","unstructured":"Holmes AV, et al. Rooming in to treat neonatal abstinence syndrome: improve family-centered care at lower cost. Pediatrics. 2016;137(6):e20152929.","journal-title":"Pediatrics"},{"key":"7378_CR11","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/jp.2014.114","volume":"34","author":"SW Patrick","year":"2014","unstructured":"Patrick SW, et al. Variation in treatment of neonatal abstinence syndrome in US Children\u2019s Hospitals, 2004\u20132011. J Perinatol. 2014;34:867\u201372.","journal-title":"J Perinatol"},{"key":"7378_CR12","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1053\/j.semperi.2015.08.013","volume":"39","author":"MW Stover","year":"2015","unstructured":"Stover MW, et al. Opioids in pregnancy and neonatal abstinence syndrome. Sem Perinatology. 2015;39:561\u20135.","journal-title":"Sem Perinatology"},{"issue":"4","key":"7378_CR13","doi-asserted-by":"publisher","first-page":"e20170900","DOI":"10.1542\/peds.2017-0900","volume":"141","author":"MC Walsh","year":"2018","unstructured":"Walsh MC, et al. Ohio perinatal quality collaborative improves care of neonatal abstinence syndrome. Pediatrics. 2018;141(4):e20170900.","journal-title":"Pediatrics"},{"key":"7378_CR14","doi-asserted-by":"publisher","first-page":"F300","DOI":"10.1136\/adc.2003.033555","volume":"89","author":"L Jackson","year":"2004","unstructured":"Jackson L, et al. A randomized controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome. Arch Dis Child Fetal Neonat Ed. 2004;89:F300\u20134.","journal-title":"Arch Dis Child Fetal Neonat Ed"},{"key":"7378_CR15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/jp.2014.194","volume":"35","author":"MS Brown","year":"2015","unstructured":"Brown MS, et al. Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized trial. J Perinatol. 2015;35:278\u201383.","journal-title":"J Perinatol"},{"key":"7378_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12887-015-0377-9","volume":"15","author":"F Nayeri","year":"2015","unstructured":"Nayeri F, et al. Phenobarbital versus morphine in the management of neonatal abstinence syndrome, a randomized controlled trial. BMC Pediatr. 2015;15:57. https:\/\/doi.org\/10.1186\/s12887-015-0377-9.","journal-title":"BMC Pediatr"},{"key":"7378_CR17","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1056\/NEJMoa1614835","volume":"376","author":"W Kraft","year":"2017","unstructured":"Kraft W, et al. Buprenorphine for the treatment of the neonatal abstinence syndrome. Ne Eng J Med. 2017;376:2341\u20138.","journal-title":"Ne Eng J Med"},{"issue":"8","key":"7378_CR18","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/jamapediatrics.2018.1307","volume":"172","author":"JM Davis","year":"2018","unstructured":"Davis JM, et al. Comparison of safety and efficacy of methadone vs morphine for treatment of neonatal abstinence syndrome A randomized trial. JAMA Pediatrics. 2018;172(8):741\u20138.","journal-title":"JAMA Pediatrics"},{"issue":"2","key":"7378_CR19","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1542\/peds.2014-2377","volume":"135","author":"HS Bada","year":"2015","unstructured":"Bada HS, et al. Morphine versus clonidine for neonatal abstinence syndrome. Pediatrics. 2015;135(2):e383\u201391.","journal-title":"Pediatrics"},{"key":"7378_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1053\/j.semperi.2015.12.007","volume":"40","author":"WK Kraft","year":"2016","unstructured":"Kraft WK, et al. Neonatal abstinence syndrome: pharmacologic strategies for the mother and infant. Seminars in Perinatol. 2016;40:203\u201312.","journal-title":"Seminars in Perinatol"},{"key":"7378_CR21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/pan.12385","volume":"24","author":"RM Ward","year":"2014","unstructured":"Ward RM, et al. The pharmacokinetics of methadone and its metabolites in neonates, infants and children. Pediatric Anes. 2014;24:591\u2013601.","journal-title":"Pediatric Anes"},{"key":"7378_CR22","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jpeds.2015.08.032","volume":"167","author":"JR Wiles","year":"2015","unstructured":"Wiles JR, et al. Pharmacokinetics of oral methadone in the treatment of neonatal abstinence syndrome: a pilot study. J Pediatr. 2015;167:1214\u201320.","journal-title":"J Pediatr"},{"key":"7378_CR23","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jpeds.2015.09.038","volume":"167","author":"ES Hall","year":"2015","unstructured":"Hall ES, et al. Cohort analysis of a pharmacokinetic-modeled methadone weaning optimization for neonatal abstinence syndrome. J Pediatr. 2015;167:1221\u20135.","journal-title":"J Pediatr"},{"key":"7378_CR24","doi-asserted-by":"publisher","first-page":"F73","DOI":"10.1136\/adc.2003.046276","volume":"90","author":"MG Coyle","year":"2005","unstructured":"Coyle MG, et al. Neurobehavioral effects of treatment for opiate withdrawal. Arch Dis Child Fetal Neonatal Ed. 2005;90:F73-74.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"7378_CR25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1542\/peds.113.S2.641","volume":"113","author":"B Lester","year":"2004","unstructured":"Lester B, et al. The Neonatal Intensive Care Unit Network Neurobehavioral Scale procedures. Pediatrics. 2004;113:641\u201367.","journal-title":"Pediatrics"},{"key":"7378_CR26","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1542\/peds.110.6.1182","volume":"110","author":"B Lester","year":"2002","unstructured":"Lester B, et al. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1 month old infants. Pediatrics. 2002;110:1182\u201392.","journal-title":"Pediatrics"},{"key":"7378_CR27","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1542\/peds.2009-0204","volume":"125","author":"J Liu","year":"2010","unstructured":"Liu J, et al. Neonatal neurobehavior predicts medical and behavioral outcome. Pediatrics. 2010;125:e90-98.","journal-title":"Pediatrics"},{"issue":"3","key":"7378_CR28","doi-asserted-by":"publisher","first-page":"e20190128","DOI":"10.1542\/peds.2019-0128","volume":"144","author":"E Conradt","year":"2019","unstructured":"Conradt E, et al. Prenatal Opioid exposure: neurodevelopmental consequences and future research priorities. Pediatrics. 2019;144(3):e20190128.","journal-title":"Pediatrics"},{"issue":"5","key":"7378_CR29","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41372-018-0088-9","volume":"38","author":"ST Merhar","year":"2018","unstructured":"Merhar ST, et al. Retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndrome. J Perinatol. 2018;38(5):587\u201392.","journal-title":"J Perinatol"},{"issue":"31","key":"7378_CR30","doi-asserted-by":"publisher","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","volume":"67","author":"SC Haight","year":"2018","unstructured":"Haight SC, et al. Opioid use disorder documented at delivery hospitalization-United States, 1999\u20132014. Morb Mortal Wkly Rep. 2018;67(31):845\u20139.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"24","key":"7378_CR31","doi-asserted-by":"publisher","first-page":"23202331","DOI":"10.1056\/NEJMoa1005359","volume":"363","author":"HE Jones","year":"2010","unstructured":"Jones HE, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Eng J Med. 2010;363(24):23202331.","journal-title":"N Eng J Med"},{"key":"7378_CR32","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","volume":"63","author":"D Cella","year":"2010","unstructured":"Cella D, Riley W, Stone AA, Rothrock N, Reeve BB, Yount S, Amtmann DDB, Choi S, Cook KF, et al. The Patient Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult selfreported health outcome item banks: 2005\u20132008. J Clin Epidemiol. 2010;63:1179\u201394.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"7378_CR33","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/NMC.0000000000000213","volume":"41","author":"KA Thomas","year":"2016","unstructured":"Thomas KA, Spieker S. Sleep, depression, and fatigue in late postpartum. MCN Am J Matern Child Nurs. 2016;41(2):104\u20139.","journal-title":"MCN Am J Matern Child Nurs"},{"issue":"4","key":"7378_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4037\/ccn2013715","volume":"33","author":"M Busse","year":"2013","unstructured":"Busse M, Stromgren K, Thorngate L, Thomas KA. Parents\u2019 responses to stress in the neonatal intensive care unit. Crit Care Nurse. 2013;33(4):52\u20139 (quiz 60).","journal-title":"Crit Care Nurse"},{"issue":"1","key":"7378_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/02646839808404558","volume":"16","author":"JT Condon","year":"1998","unstructured":"Condon JT, et al. The assessment of parent-infant attachment: development of a self-report questionnaire instrument. J Reprod Infant Psychol. 1998;16(1):57\u201376.","journal-title":"J Reprod Infant Psychol"},{"issue":"4","key":"7378_CR36","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00737-016-0602-z","volume":"19","author":"L Rossen","year":"2016","unstructured":"Rossen L, et al. Predictors of postnatal mother-infant bonding: the role of antenatal bonding, maternal substance use and mental health. Arch Womens Ment Health. 2016;19(4):609\u201322. https:\/\/doi.org\/10.1007\/s00737-016-0602-z.","journal-title":"Arch Womens Ment Health."},{"key":"7378_CR37","volume-title":"Brief Infant-Toddler Social and Emotional Assessment (BITSEA)","author":"M Briggs-Gowan","year":"2002","unstructured":"Briggs-Gowan M, Carter A. Brief Infant-Toddler Social and Emotional Assessment (BITSEA). New Haven CT: Yale University; 2002."},{"issue":"2","key":"7378_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/jpepsy\/jsh017","volume":"29","author":"MJ Briggs-Gowan","year":"2004","unstructured":"Briggs-Gowan MJ, Carter AS, Irwin JR, Wachtel K, Cicchetti DV. The Brief Infant-Toddler Social and Emotional Assessment: screening for social-emotional problems and delays in competence. J Pediatr Psychol. 2004;29(2):143\u201355.","journal-title":"J Pediatr Psychol"},{"issue":"4","key":"7378_CR39","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.infbeh.2010.07.001","volume":"33","author":"K Karabekiroglu","year":"2010","unstructured":"Karabekiroglu K, Briggs-Gowan MJ, Carter AS, Rodopman-Arman A, Akbas S. The clinical validity and reliability of the Brief Infant-Toddler Social and Emotional Assessment (BITSEA). Infant Behav Dev. 2010;33(4):503\u20139.","journal-title":"Infant Behav Dev"},{"issue":"2","key":"7378_CR40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1177\/0734282906297199","volume":"25","author":"CA Albers","year":"2007","unstructured":"Albers CA, Grieve AJ. Review of Bayley Scales of Infant and Toddler Development-Third Edition. J Psychoeducational Assess. 2007;25(2):180\u201390.","journal-title":"J Psychoeducational Assess"},{"issue":"9","key":"7378_CR41","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s11136-011-9882-y","volume":"20","author":"LE Gibbons","year":"2011","unstructured":"Gibbons LE, Feldman BJ, Crane HM, Mugavero M, Willig JH, Patrick D, et al. Migrating from a legacy fixed-format measure to CAT administration: calibrating the PHQ-9 to the PROMIS depression measures. Qual Life Res. 2011;20(9):1349\u201357.","journal-title":"Qual Life Res"},{"key":"7378_CR42","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jpsychires.2014.05.010","volume":"56","author":"PA Pilkonis","year":"2014","unstructured":"Pilkonis PA, Yu L, Dodds NE, Johnston KL, Maihoefer CC, Lawrence SM. Validation of the depression item bank from the Patient-Reported Outcomes Measurement Information System (PROMIS) in a three-month observational study. J Psychiatr Res. 2014;56:112\u20139.","journal-title":"J Psychiatr Res"},{"key":"7378_CR43","unstructured":"E9(R1) Statistical Principles for Clinical Trials: Addendum: Estimands and Sensitivity Analysis in Clinical Trials. Published June 6,2017; Updated May 11,2021. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/e9r1-statistical-principles-clinical-trials-addendum-estimands-and-sensitivity-analysis-clinical (2021, Accessed 26 Feb 2023)"},{"key":"7378_CR44","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1542\/peds.48.2.178","volume":"48","author":"C Zelson","year":"1971","unstructured":"Zelson C, et al. Neonatal narcotic addiction: 10 year observation. Pediatrics. 1971;48:178\u201389.","journal-title":"Pediatrics"},{"issue":"1","key":"7378_CR45","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/archpedi.1974.02110200060008.PMID:4809795","volume":"127","author":"SR Kandall","year":"1974","unstructured":"Kandall SR, Gartner LM. Late presentation of drug withdrawal symptoms in newborns. Am J Dis Child. 1974;127(1):58\u201361. https:\/\/doi.org\/10.1001\/archpedi.1974.02110200060008.PMID:4809795.","journal-title":"Am J Dis Child"},{"key":"7378_CR46","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S0022-3476(77)80523-4","volume":"91","author":"RA Herzlinger","year":"1977","unstructured":"Herzlinger RA, et al. Neonatal seizures associated with narcotic withdrawal. J Pediatr. 1977;91:638\u201341.","journal-title":"J Pediatr"},{"issue":"21","key":"7378_CR47","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1080\/14767058.2019.1579190","volume":"33","author":"J Limjoco","year":"2020","unstructured":"Limjoco J, Zawadzki L, Belden M, Eickhoff J, Ikonomidou C. Amplitude-integrated EEG use in neonatal abstinence syndrome: a pilot study. J Matern Fetal Neonatal Med. 2020;33(21):3565\u201370.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"7378_CR48","doi-asserted-by":"crossref","unstructured":"Palla MR, et al, EEG findings in infants with neonatal abstinence syndrome presenting with clinical seizures. Frontiers in Pediatrics 2019;.\u00a010.3389\/fped.2019.00111","DOI":"10.3389\/fped.2019.00111"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07378-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07378-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07378-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T13:05:39Z","timestamp":1689944739000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07378-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7378"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07378-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"assertion":[{"value":"29 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Original approval letter from cIRB is attached.Name of the ethics committee that approved the study: University of Arkansas for Medical Sciences Institutional Review Board.Committee\u2019s reference number: FWA00001119.Protocol Number: 260053 \u2013 University of Arkansas for Medical Sciences Institutional Review Board FWA00001119. Written, informed consent, and when applicable written informed assent, will be obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable - no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. Informed consent materials are attached as supplementary materials.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The study investigators have no financial conflicts of interest (FCOI) related to the study outlined in this protocol. We will handle any potential or perceived conflicts of interest, including FCOI, per Title 42, Code of Federal Regulations, Part 50, Subpart F (50.604 Responsibilities of Institutions regarding Investigator financial conflicts of interest). This states that institutional officials (and all subrecipients) are required to notify the grants officer of any FCOI prior to expenditure of any funds and within 60 days of any subsequently identified FCOI. The research team will simultaneously notify NICHD, ECHO office, the NRN Steering Committee, and the ISPCTN Steering Committee regarding the COI management plan, following institutional guidelines of each participating hospital.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"466"}}